185 related articles for article (PubMed ID: 31527488)
1. Investigation of Metal-Organic Framework-5 (MOF-5) as an Antitumor Drug Oridonin Sustained Release Carrier.
Chen G; Luo J; Cai M; Qin L; Wang Y; Gao L; Huang P; Yu Y; Ding Y; Dong X; Yin X; Ni J
Molecules; 2019 Sep; 24(18):. PubMed ID: 31527488
[TBL] [Abstract][Full Text] [Related]
2. Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers.
Leng X; Dong X; Wang W; Sai N; Yang C; You L; Huang H; Yin X; Ni J
Molecules; 2018 Sep; 23(10):. PubMed ID: 30274195
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Application of a pH-Responsive Functional Metal-Organic Framework: In Vitro Investigation for Delivery of Oridonin in Cancer Therapy.
Shen J; Gao F; Pan Q; Zong Z; Liang L
Molecules; 2024 Jun; 29(11):. PubMed ID: 38893518
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable self-assembled MPEG-PCL micelles for hydrophobic oridonin delivery in vitro.
Xue B; Wang Y; Tang X; Xie P; Wang Y; Luo F; Wu C; Qian Z
J Biomed Nanotechnol; 2012 Feb; 8(1):80-9. PubMed ID: 22515096
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
Li C; Zhang D; Guo H; Hao L; Zheng D; Liu G; Shen J; Tian X; Zhang Q
Int J Pharm; 2013 May; 448(1):79-86. PubMed ID: 23518367
[TBL] [Abstract][Full Text] [Related]
6. Morphology- and size-controlled synthesis of a metal-organic framework under ultrasound irradiation: An efficient carrier for pH responsive release of anti-cancer drugs and their applicability for adsorption of amoxicillin from aqueous solution.
Abazari R; Reza Mahjoub A; Slawin AMZ; Carpenter-Warren CL
Ultrason Sonochem; 2018 Apr; 42():594-608. PubMed ID: 29429708
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo.
Shi X; Peng T; Huang Y; Mei L; Gu Y; Huang J; Han K; Li G; Hu C; Pan X; Wu C
Pharm Dev Technol; 2017 May; 22(3):322-329. PubMed ID: 26670780
[TBL] [Abstract][Full Text] [Related]
8. The anti-tumor effect of folate-targeted liposome microbubbles loaded with oridonin as ultrasound-triggered tumor-targeted therapeutic carrier system.
Wang C; Li W; Hu B
J Drug Target; 2017 Jan; 25(1):83-91. PubMed ID: 27282800
[TBL] [Abstract][Full Text] [Related]
9. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
10. Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system.
Javanbakht S; Pooresmaeil M; Namazi H
Carbohydr Polym; 2019 Mar; 208():294-301. PubMed ID: 30658803
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.
Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q
Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003
[TBL] [Abstract][Full Text] [Related]
12. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
13. Novel galactosylated biodegradable nanoparticles for hepatocyte-delivery of oridonin.
Wang Y; Liu X; Liu G; Guo H; Li C; Zhang Y; Zhang F; Zhao Z; Cheng H
Int J Pharm; 2016 Apr; 502(1-2):47-60. PubMed ID: 26911417
[TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.
Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B
Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104
[TBL] [Abstract][Full Text] [Related]
15. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
[TBL] [Abstract][Full Text] [Related]
16. GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
Pi J; Jiang J; Cai H; Yang F; Jin H; Yang P; Cai J; Chen ZW
Drug Deliv; 2017 Nov; 24(1):1549-1564. PubMed ID: 29019267
[TBL] [Abstract][Full Text] [Related]
17. Thermal Stimuli-Triggered Drug Release from a Biocompatible Porous Metal-Organic Framework.
Jiang K; Zhang L; Hu Q; Zhang Q; Lin W; Cui Y; Yang Y; Qian G
Chemistry; 2017 Jul; 23(42):10215-10221. PubMed ID: 28682004
[TBL] [Abstract][Full Text] [Related]
18. Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer.
Yan X; Zhao X; Fan M; Zheng W; Zhu G; Li B; Wang L
Int J Nanomedicine; 2024; 19():3847-3859. PubMed ID: 38708182
[TBL] [Abstract][Full Text] [Related]
19. Zirconium-Porphyrin PCN-222: pH-responsive Controlled Anticancer Drug Oridonin.
Leng X; Huang H; Wang W; Sai N; You L; Yin X; Ni J
Evid Based Complement Alternat Med; 2018; 2018():3249023. PubMed ID: 30622595
[TBL] [Abstract][Full Text] [Related]
20. Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
Nejadshafiee V; Naeimi H; Goliaei B; Bigdeli B; Sadighi A; Dehghani S; Lotfabadi A; Hosseini M; Nezamtaheri MS; Amanlou M; Sharifzadeh M; Khoobi M
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():805-815. PubMed ID: 30889755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]